Skip to content

GORE PROPATEN Vascular Graft HAX02ARecalls & reported problems

W. L. Gore & Associates, Inc. · PROPATEN VASC GRAFT SW RR AXBI 8mmX90cm 8mmX40cm Heparin · Class 2 · Implant

All models of GORE PROPATEN Vascular Graft (11)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132617692), received between Oct 22, 2019 and Jan 27, 2025 — classified as 2 injuries.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Patient Device Interaction Problem1
  • Patient-Device Incompatibility1

Patient problems

  • Bacterial Infection1
  • Seroma1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 27, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    ON (B)(6) 2023, A PATIENT REPORTEDLY UNDERWENT TREATMENT FOR PERIPHERAL ARTERIAL DISEASE (OCCLUDED DISTAL AORTA AND BILATERAL COMMON ILIAC ARTERIES) WITH DEBILITATING SHORT DISTANCE CLAUDICATION AND RIGHT LEG WOUNDS, WHERE A GORE® PROPATEN® VASCULAR GRAFT WAS USED IN AN AXILLO-BIFEMORAL BYPASS WITH BILATERAL FEMORAL ENDARTERECTOMY PROCEDURE. IT WAS ALLEGED THERE WAS NO INFECTION PRESENT AT THE TIME OF THE SURGERY. ON (B)(6), 2023 (53 DAYS POST INITIAL SURGERY), THE PATIENT REPORTEDLY PRESENTED AT THE HOSPITAL WITH PAIN IN LOWER BACK, FEVER, AND SOME DISCHARGE FROM RIGHT GROIN INCISION. ON (B)(6) 2023, THE PATIENT UNDERWENT EMERGENCY EXPLORATORY SURGERY. IT WAS REPORTED, DURING THE PROCEDURE, AN UNINCORPORATED PORTION OF THE GRAFT THAT APPEARED TO BE INFECTED (SIGNS OF PURULENCE AND DISRUPTED SUTURE LINE) WAS EXPLANTED. THE REMAINING GRAFT ON THE RIGHT SIDE AND THE ENTIRE GRAFT ON THE LEFT SIDE OF THE PATIENT WERE NOT EXPLANTED. ON (B)(6) 2024 THE PATIENT WAS REPORTEDLY DISCHARGED AND TRANSFERRED TO ANOTHER FACILITY. ON (B)(6) 2024. THE PATIENT WAS ALLEGEDLY READMITTED TO THE FIRST HOSPITAL AND BLOODWORK CONFIRMED THE PRESENCE OF STAPHYLOCOCCUS AUREUS IN SYSTEM, INDICATING ON-GOING

    Patient problems: Bacterial Infection

    MAUDE report 21242741 ↗
  • InjuryOct 22, 2019Patient-Device Incompatibility; Patient-Device Incompatibility

    THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2019, A GORE® PROPATEN® VASCULAR GRAFT (STANDARD-WALLED, AXILLOBIFEMORAL, REMOVABLE RINGED) WAS IMPLANTED USING A GORE TUNNELER. AROUND (B)(6) 2019 (REPORTED AS 6-8 WEEKS AGO), PATIENT RECEIVED TREATMENT DUE TO SEROMA. CLEAR FLUID WAS DRAINED. ANOTHER INTERVENTION WAS PERFORMED AFTER (B)(6) (DATE UNSPECIFIED) AND CLEAR FLUID WAS DRAINED AGAIN. AS REPORTED, FLUID WAS TESTED EACH TIME. CULTURES WERE NEGATIVE FOR INFECTION AND THERE WAS NO BLOOD IN THE ASPIRATED FLUID. ON (B)(6) 2019, PATIENT PRESENTED WITH SEROMA AND CLEAR FLUID WAS DRAINED AGAIN. DURING THIS INTERVENTION, THE VASCULAR GRAFT WAS RELINED ALMOST ENTIRELY WITH SEVERAL GORE® VIABAHN® ENDOPROSTHESES. BEFORE IMPLANTATION, CAT SCAN MEASUREMENTS WERE TAKEN TO ENSURE CORRECT SIZING. IT WAS REPORTED ONLY A 4 CM SEGMENT WAS LEFT UNLINED. A DRAINAGE TUBE WAS LEFT IN PLACE. PATIENT WAS REPORTED TO BE RECOVERING WELL FOLLOWING THE PROCEDURE.

    Patient problems: Seroma

    MAUDE report 9221646 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page